您要查找的是不是：
- Objective To survey the mutuality of chronic severe hepatitis on peripheral blood cell and its results. 目的通过对慢性重型肝炎患者的外周血象分析,观察慢性重型肝炎的外周血象与其预后的相关性。
- Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver. 目的 应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝 ,进一步评价其安全性和疗效。
- Aim To observe the clinical therapeutic effects and adverse reaction of Lipo-PGE1 in treament of chronic severe hepatitis. 目的 观察前列腺素E1脂微球载体制剂 (凯时 ,Lipo PGE1)对慢性重症肝炎的治疗作用和副作用。
- Objective To analysis the inconsistent reason of clinical diagnosis and pathology diagnosis of chronic severe hepatitis (CSH). 摘要目的分析慢性重型肝炎(CSH)临床与病理诊断不相一致的原因。
- Results In liver disease group, the levels of PLD in patients with chronic hepatitis, chronic severe hepatitis and liver cirrhosis were sta... 05或0。01),且以肝硬变升高幅度最为显著。结论PLD活性测定是一项反映慢肝病患者肝脏纤维化的良好指标之一。
- Objective To evaluate the treatment of plasma exchange (PE) in patients with chronic severe hepatitis based on prothrombin activity (PTA). 摘要目的探讨根据凝血酶原活动度(PTA)预测重型肝炎高胆红素血症行血浆置换的临床疗效。
- Objective To observe the clinical effect of plasma-exchange therapy(PET) for chronic severe hepatitis B(CSH-B) and its influential factors. 目的观察血浆置换治疗慢性乙型重型肝炎的临床效果及其影响因素。
- Cai CJ, Lu MQ, Chong YT, et al.An evaluation of the prognosis of patients with chronic severe hepatitis using a model for end-stage liver disease. 蔡常洁，陆敏强，崇雨田，等.;应用终末期肝病模型对慢性重型肝炎患者的预后评估
- Objective: To evaluate the clinical efficiency of colon dialysis therapy with traditional Chinese and western medicine on chronic severe hepatitis. 摘要目的：观察中西医结合结肠透析疗法对慢性重型肝炎的临床疗效。
- Objective To study the complication of artificial liver support system(ALSS) on treating patients with chronic severe hepatitis. 目的 探讨人工肝支持系统（ALSS）治疗慢性重型肝炎时并发症的发生及其防治措施。
- Objective To observe the clinical effect of plasma-exchange therapy (PET) for chronic severe hepatitis B (CSH-B) and its influential factors. 摘要目的观察血浆置换治疗慢性乙型重型肝炎的临床效果及其影响因素。
- Conclusion: Clinical manifestations of chronic severe hepatitis with idiopathic peritonitis are not representative and various. 结论：慢性重型肝炎合并原发性腹膜炎临床表现不典型、多样性。
- Objective To analysis the inconsistent reason of clinical diagnosis and pathology diagnosis of chronic severe hepatitis(CSH). 目的分析慢性重型肝炎(CSH)临床与病理诊断不相一致的原因。
- Objective To investigate the curative effect and safety of auxiliary treatment with Suanzaoren Decoction SZRD on patients with chronic severe hepatitis. 目的研究酸枣仁汤辅助治疗慢性重型肝炎的疗效及安全性。
- Objective: To diagnose and cure early and improve survival rate by investigating the clinic characteristic and outcome of chronic severe hepatitis with idiopathic peritonitis. 摘要目的：探讨慢性重型肝炎合并原发性腹膜炎的临床特点及预后，旨在尽早诊断，早治疗，提高生存率。
- Conclusion Ursofalk combined with artificial liver treatment and conventional therapy is safe and more effective in treatment of chronic severe hepatitis. 结论 优思弗联合人工肝治疗慢性重型肝炎是安全和有效的。
- AIM: To observe the therapeutic effect of hepatocyte growth promoting factor (PHGF) combined with transmetil in treatment of chronic severe hepatitis (CSF). 目的:观察促肝细胞生长素联合腺苷蛋氨酸治疗慢重肝的疗效。
- The positive rate of HCV Ags expression was 45% (9/20) in severe viral hepatitis, 60% (6/10) in chronic severe hepatitis, 42.9% (3/7) in subacute severe hepatitis and 0%(0/3) in acute severe hepatitis. 肝组织内HCV抗原表达阳性率45%25（9/20），其中慢性重型肝炎60%25（6/10），亚急性42.;9（3/7），急性0%25（0/3）。
- Results The level of TBA in chronic severe hepatitis was higher than that in other groups( P <0.01), the change of TBA in chronic severe hepatitis was parallel with TBIL and contrary... 治愈+好转组TBA明显低于恶化+死亡组(P<0.;01)。结论慢性重型肝炎TBA显著升高;肝细胞损伤越严重;TBA水平越高。TBA是敏感的肝功能检测指标;对慢性重型肝炎的疗效及预后评估有一定的临床价值。
- Method According to the serum biochemical indicators and clinical symptoms we make out clinical diagnosis and pathological diagnosis for the liver tissue of chronic severe hepatitis. 方法根据血清生化指标与临床症状对患者做出临床诊断，再对慢性重型肝炎肝组织做病理诊断。
